Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.930
-0.020 (-1.03%)
Dec 26, 2024, 4:00 PM EST - Market closed
PACB Analyst Ratings
Total Analysts
13
Consensus Rating
Buy
Price Target
$2.92
Upside
+51.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades $2 | Strong Buy → Hold | Downgrades | $2 | +3.63% | Nov 11, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $7 → $6 | Buy | Maintains | $7 → $6 | +210.88% | Nov 11, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $2 → $2.5 | Hold | Maintains | $2 → $2.5 | +29.53% | Nov 11, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +262.69% | Aug 28, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $3.5 → $2.5 | Buy | Maintains | $3.5 → $2.5 | +29.53% | Aug 13, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | +3.63% | Aug 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $3.5 | Buy | Reiterates | $3.5 | +81.35% | Aug 8, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $3.5 → $3 | Strong Buy | Maintains | $3.5 → $3 | +55.44% | Aug 8, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $4 | Strong Buy | Initiates | $4 | +107.25% | Jun 3, 2024 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $10 → $4 | Hold | Maintains | $10 → $4 | +107.25% | May 15, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $6.5 → $2 | Hold | Maintains | $6.5 → $2 | +3.63% | May 13, 2024 |
| Barclays | Barclays | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | +3.63% | May 10, 2024 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Apr 22, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $7 → $2.5 | Hold | Maintains | $7 → $2.5 | +29.53% | Apr 19, 2024 |
| Bernstein | Bernstein | Buy Maintains $9 → $2.5 | Buy | Maintains | $9 → $2.5 | +29.53% | Apr 18, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $7 → $2.5 | Strong Buy → Hold | Downgrades | $7 → $2.5 | +29.53% | Apr 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.